AbbVie (ABBV) announced that it has completed its acquisition of Landos Biopharma (LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie Completes Acquisition of Landos Biopharma
- Robinhood upgraded, Baidu downgraded: Wall Street’s top analyst calls
- AbbVie initiated with an Overweight at Cantor Fitzgerald
- 3 Best Value Stocks to Buy in May 2024, According to Analysts
- AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies